Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival
- 1 February 1995
- journal article
- Published by Elsevier in Mathematical Biosciences
- Vol. 125 (2) , 127-153
- https://doi.org/10.1016/0025-5564(94)00021-q
Abstract
No abstract availableKeywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virusPublished by Elsevier ,2004
- Targeted Defective Interfering HIV-1 Particles as Renewable Antivirals?Published by Springer Nature ,1995
- Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDSNature, 1993
- Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication—potential effectiveness against most presently sequenced HIV-1 isolatesNucleic Acids Research, 1992
- HIV I Infection of Dendritic CellsInternational Reviews of Immunology, 1990
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Defective Interfering Viruses and Infections of AnimalsPublished by Springer Nature ,1986
- Modulation of Semliki Forest Virus-Induced Infection of Mice by Defective-Interfering VirusThe Journal of Infectious Diseases, 1984
- Defective Interfering VirusesAnnual Review of Microbiology, 1973
- Defective Viral Particles and Viral Disease ProcessesNature, 1970